Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018045

« Back to Dashboard
NDA 018045 describes EMCYT, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from one supplier. Additional details are available on the EMCYT profile page.

The generic ingredient in EMCYT is estramustine phosphate sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the estramustine phosphate sodium profile page.

Summary for NDA: 018045

Pharmacia And Upjohn
estramustine phosphate sodium
Therapeutic Class:Antineoplastics

Pharmacology for NDA: 018045

Suppliers and Packaging for NDA: 018045

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
estramustine phosphate sodium
CAPSULE;ORAL 018045 NDA Pharmacia and Upjohn Company 0013-0132 0013-0132-02 1 BOTTLE in 1 CARTON (0013-0132-02) > 100 CAPSULE in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 140MG PHOSPHATE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.